Oncology data evolves and emerges at a rapid pace leading to a proliferation of new actionable mutations, therapeutic targets, new therapies, and changes in treatment sequencing. The Keeping Pace in Oncology CME series has been developed to synthesize the latest data from clinical trials to help community oncologists keep pace with the rapid changes and best practices for integrating advances into clinical practice. Educational modules feature conversations with leading experts to explore clinical insights and perspectives on patient-centered treatment.
Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)
Keeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma